www.taro.com

Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.


Investor Relations
Corporate Profile
Welcome to Taro’s Investor Relations Website
Established in 1950, Taro Pharmaceutical Industries Ltd. is a research-based, international, specialty pharmaceutical company that develops, manufactures and markets prescription and over-the-counter pharmaceutical products. Taro’s research programs and niche strategy have enabled the Company to achieve leadership in dermatological products in the U.S.

Growth Through Research
Taro’s investments in research have enabled it to become a U.S. leader in topical prescription products (creams, ointments and gels). Approximately 1 in 8 tubes of such products sold in the U.S. are supplied by Taro. The Company also specializes in medicines used in cardiology, pediatrics and neurology.

International Operations, U.S. Expansion
Taro has research, manufacturin... 
More >>

 

TARO (Common Stock)
ExchangeNYSE (US Dollar)
Price$63.97
Change (%) Stock is Up 1.11 (1.77%)
Volume32,917
Data as of 05/17/13 4:02 p.m. ET
Click Here for Stock Quote Data on NYSE
Recent NewsMore >>
DateTitle 
05/16/13Taro to Announce Results for Year Ended March 31, 2013Printer Friendly Version
04/12/13Taro Receives FDA Approval For Topicort® (desoximetasone) Topical Spray, 0.25%Printer Friendly Version
02/08/13Sun Pharma and Taro Announce Termination of Proposed TransactionPrinter Friendly Version
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

Useful Taro Links
  |  
Terms of Use
  |  
Privacy Statement
  |  
Safe Harbor Statement